NASDAQ:CDT

Conduit Pharmaceuticals Stock Forecast

etoro logo Buy CDT
*Your capital is at risk
$3.11
-0.310 (-9.06%)
At Close: Aug 10, 2026

Should you buy CDT stock?

Last updated:

Based on market data through , StockInvest.us rates Conduit Pharmaceuticals Inc. (CDT) as a Sell Candidate with a technical score of -4.88 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Sell signal since
  • Price since signal Down 4.89%
  • 3-month trend forecast Down 64.60%
  • Sell Candidate -4.88
AI Analysis AI Analysis of CDT AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CDT to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Volatile ride for Conduit Pharmaceuticals Inc. stock price on Monday moving between $3.00 and $3.45
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 23, 2026 Loss -4.89%

The Conduit Pharmaceuticals Inc. stock price fell by -9.06% on the last day (Monday, 10th Aug 2026) from $3.42 to $3.11. During the last trading day the stock fluctuated 15.00% from a day low at $3.00 to a day high of $3.45. The price has risen in 6 of the last 10 days and is up by 9.31% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -25 thousand shares and in total, 41 thousand shares were bought and sold for approximately $126.61 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CDT Signals & Forecast

There are mixed signals in the stock today. The Conduit Pharmaceuticals Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.18 and $4.61. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. A buy signal was issued from a pivot bottom point on Wednesday, July 29, 2026, and so far it has risen 21.96%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Conduit Pharmaceuticals Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.94 and $2.87. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Conduit Pharmaceuticals Inc. finds support just below today's level at $2.94. If this is broken, then the next support from accumulated volume will be at $2.87 and $2.55.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.450 between high and low, or 15.00%. For the last week the stock has had daily average volatility of 15.64%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CDT) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Conduit Pharmaceuticals Inc. to open at $3.19, and during the day (based on 14 day Average True Range), to move between $2.74 and $3.48, which gives a possible trading interval of +/-$0.735 (+/-26.79%) up or down from last closing price. If Conduit Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 26.79% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.94 (5.47%) than the resistance at $3.57 (14.63%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Conduit Pharmaceuticals Inc. stock A Buy?

Conduit Pharmaceuticals Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -4.879 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $3.19 ( 2.46%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CDT Performance

Trading levels for CDT

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.64 16.93%
R2 3.46 11.40%
R1 3.36 7.99%
Price 3.11
S1 3.01 -3.06%
S2 2.91 -6.48%
S3 2.74 -12.00%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.83 23.15%
R2 3.59 15.43%
R1 3.57 14.63%
Price 3.11
S1 2.94 -5.47%
S2 2.87 -7.72%
S3 2.55 -18.01%

FAQ

What is the symbol for Conduit Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for Conduit Pharmaceuticals Inc. is CDT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Conduit Pharmaceuticals Inc. Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Conduit Pharmaceuticals Inc. (CDT) as a Sell Candidate with a technical score of -4.88 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Sell signal began on Jul 23, 2026, the price has fallen 4.89%. The current 3-month trend forecast projects a fall of 64.60%.

How to buy Conduit Pharmaceuticals Inc. Stock?
Conduit Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Conduit Pharmaceuticals Inc. Stock.

What's the current price of Conduit Pharmaceuticals Inc. Stock?
As of the end of day on the Aug 10, 2026, the price of an Conduit Pharmaceuticals Inc. (CDT) share was $3.11.

What is the 52-week high and low for Conduit Pharmaceuticals Inc. Stock?
The 52-week high for Conduit Pharmaceuticals Inc. Stock is $1,125.00 and the 52-week low is $2.53.

What is the market capitalization of Conduit Pharmaceuticals Inc. Stock?
As of the Aug 10, 2026, the market capitalization of Conduit Pharmaceuticals Inc. is 1.511M.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE